• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: Effect of Immunotherapy Time-of-day Infusion on Overall Survival Among Patients with Advanced Melanoma in the USA (MEMOIR): A Propensity Score-matched Analysis of a Single-centre, Longitudinal Study.

作者信息

Santoni Matteo, Molina-Cerrillo Javier, Massari Francesco, Montironi Rodolfo, Grande Enrique

机构信息

Oncology Unit, Macerata Hospital, Macerata, Italy.

Medical Oncology Department, Ramón y Cajal University Hospital, Medical School, Alcala University, Madrid, Spain; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

出版信息

Eur Urol. 2022 Jun;81(6):623-624. doi: 10.1016/j.eururo.2022.03.017. Epub 2022 Mar 30.

DOI:10.1016/j.eururo.2022.03.017
PMID:35367085
Abstract
摘要

相似文献

1
Re: Effect of Immunotherapy Time-of-day Infusion on Overall Survival Among Patients with Advanced Melanoma in the USA (MEMOIR): A Propensity Score-matched Analysis of a Single-centre, Longitudinal Study.回复：美国晚期黑色素瘤患者免疫治疗输注时间对总生存期的影响（MEMOIR）：一项单中心纵向研究的倾向得分匹配分析
Eur Urol. 2022 Jun;81(6):623-624. doi: 10.1016/j.eururo.2022.03.017. Epub 2022 Mar 30.
2
Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study.美国晚期黑色素瘤患者免疫疗法日间输注时间对总生存期的影响（MEMOIR）：一项单中心纵向研究的倾向评分匹配分析。
Lancet Oncol. 2021 Dec;22(12):1777-1786. doi: 10.1016/S1470-2045(21)00546-5. Epub 2021 Nov 12.
3
First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF-mutant advanced melanoma patients: a propensity-matched survival analysis.一线 BRAF/MEK 抑制剂与 BRAF 突变型晚期黑色素瘤患者的抗 PD-1 单药治疗：一项倾向评分匹配生存分析。
Br J Cancer. 2021 Mar;124(7):1222-1230. doi: 10.1038/s41416-020-01229-1. Epub 2021 Jan 26.
4
Patients with in-transit melanoma metastases have comparable survival outcomes following isolated limb infusion or intralesional PV-10-A propensity score matched, single center study.在一项倾向评分匹配的单中心研究中，患有转移性黑色素瘤的患者在接受隔离肢体灌注或瘤内注射PV-10后具有可比的生存结果。
J Surg Oncol. 2019 May;119(6):717-727. doi: 10.1002/jso.25373. Epub 2019 Jan 15.
5
Next-generation sequencing in advanced Chinese melanoma reveals therapeutic targets and prognostic biomarkers for immunotherapy.中国晚期黑色素瘤的下一代测序揭示了免疫治疗的治疗靶点和预后生物标志物。
Sci Rep. 2022 Jun 10;12(1):9559. doi: 10.1038/s41598-022-13391-y.
6
Chemotherapy and chemoimmunotherapy for metastatic malignant melanoma: review and recent advances.转移性恶性黑色素瘤的化疗与化疗免疫疗法：综述及最新进展
Gan To Kagaku Ryoho. 2000 May;27 Suppl 2:238-47.
7
The intriguing effect of delay time to sentinel lymph node biopsy on survival: a propensity score matching study on a cohort of melanoma patients.前哨淋巴结活检延迟时间对生存的有趣影响：一项针对黑色素瘤患者队列的倾向评分匹配研究。
Eur J Dermatol. 2017 Oct 1;27(5):487-495. doi: 10.1684/ejd.2017.3065.
8
Real-world treatment patterns and overall survival in -mutant melanoma patients treated with immunotherapy or targeted therapy.真实世界中免疫治疗或靶向治疗治疗后 - 突变黑色素瘤患者的治疗模式和总生存情况。
Future Oncol. 2022 Jun;18(18):2233-2245. doi: 10.2217/fon-2021-1536. Epub 2022 Apr 20.
9
Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study.免疫治疗或靶向治疗转移性黑色素瘤患者的皮肤副作用和皮肤不良反应类型：一项回顾性单中心研究。
Dermatol Ther. 2022 Jun;35(6):e15492. doi: 10.1111/dth.15492. Epub 2022 May 10.
10
Does continuous-infusion interleukin-2 increase survival in metastatic melanoma?
Am J Clin Oncol. 2003 Apr;26(2):141-5. doi: 10.1097/00000421-200304000-00008.

引用本文的文献

1
The role of non-coding RNA in ferroptosis of liver cancer and its impact on lipid peroxidation.非编码RNA在肝癌铁死亡中的作用及其对脂质过氧化的影响。
Front Immunol. 2025 Mar 26;16:1555518. doi: 10.3389/fimmu.2025.1555518. eCollection 2025.
2
Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic Consequences.生物钟基因和昼夜节律在肾细胞癌中的作用：最新证据及治疗意义
Cancers (Basel). 2023 Jan 7;15(2):408. doi: 10.3390/cancers15020408.